A Double-blind, Randomize, Placebo-controlled Trial of Adjunctive Ganaxolone Treatment in Children and Young Adults with Cyclindependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) Followed by Long-term Open-label Treatment

Project: Research

Project Details

Project Description

NMA HREC Reference Number: 46549
NMA SSA Reference Number: SSA/46549/MonH-2019-165777(v1)
Monash Health Ref: RES-19-0000-126
Effective start/end date14/08/1913/08/24


  • clinical trial
  • treatment efficacy
  • neurodevelopment disorder